CLDX icon

Celldex Therapeutics

167 hedge funds and large institutions have $1.65B invested in Celldex Therapeutics in 2022 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 64 increasing their positions, 52 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

more funds holding in top 10

Funds holding in top 10:

6% less capital invested

Capital invested by funds: $1.75B → $1.65B (-$104M)

7% less funds holding

Funds holding: 179167 (-12)

33% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 30

Holders
167
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
7
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$72.7M
Puts
$39.3M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
76
$1.19M
77
$1.13M
78
$1.12M
79
$1.11M
80
$1.1M
81
$1.09M
82
$1.09M
83
$986K
84
$936K
85
$877K
86
$859K
87
$835K
88
$804K
89
$778K
90
$674K
91
$671K
92
$616K
93
$612K
94
$606K
95
$572K
96
$559K
97
$532K
98
$481K
99
$476K
100
$475K